Introduction: Periosteum plays a key role in bone repair via activation of residing stem/progenitor cells. The molecular signals regulating differentiation and expansion of periosteal stem cells during early repair are poorly understood. Understanding the molecular basis for initiation and completion of bone healing is vital for the success of bone tissue engineering and regeneration therapy for impaired bone healing.
To further characterize the efficiency of TM induced recombination in repair tissue, a mid-diaphyseal femur fracture was created in R26CreER;R26R mouse. TM was administered for one (day1), two (day 1 and 3) and three times (day 1, 3 and 5) post-fracture at a dose of 1mg/mouse. All samples were harvested at day10 post-fracture. We found that two ip. injections of TM were sufficient to induce recombination in nearly 70% of the reparative tissues in fracture callus. And threetime injection of TM induced recombination in 80% of repair tissue in fracture callus. Remarkably, we found that the percentage of LacZ positive cells was much higher in the callus than in its surrounding tissue or in growth plate, particularly at low dosing treatment.
Discussion: Targeted gene deletion specific to adult periosteum has not been realized due to poorly defined cell populations and the absence of specific markers. The live segmental bone graft transplantation approach allows us to indiscriminately analyze the residing progenitor cells via tracking donor cell fate and evaluating their contribution to healing. If combined with a TM inducible CreER mouse model, this approach could achieve an inducible gene targeting in early periosteal stem/progenitor cells. In view of the fact that mesenchymal stem cells come from different sources, the global inducible model holds a better chance to induce recombination in various adult progenitor cell pools. The efficient recombination in early stem/progenitor cells further results in an efficient removal of the targeted gene from all progeny following cortical bone fracture or osteotomy.
Identifying essential signals for stem/progenitor dependent bone healing is of paramount importance. Our inability to treat patients with impaired bone healing is largely due to our limited understanding of the molecular signals or signaling that are essential for this process. The presented data represent a novel approach to achieve efficient global gene targeting in adult repair tissues. If combined with bone graft transplantation, a selectively targeted gene deletion can be achieved only in periosteal progenitor cells and their progeny around bone graft. When incorporated with appropriate floxed mice, this approach can be used to examine the function of genes in controlling donor periosteal progenitor cell fate and cell dependent healing in adult repair.
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